ロード中...

The Identification of Immunological Biomarkers in Kidney Cancers

The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...

詳細記述

保存先:
書誌詳細
出版年:Front Oncol
主要な著者: Lopez-Beltran, Antonio, Henriques, Vanessa, Cimadamore, Alessia, Santoni, Matteo, Cheng, Liang, Gevaert, Thomas, Blanca, Ana, Massari, Francesco, Scarpelli, Marina, Montironi, Rodolfo
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225533/
https://ncbi.nlm.nih.gov/pubmed/30450335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00456
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!